TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,144,336 | -8.1% | 267,895 | -6.7% | 0.00% | -20.0% |
| Q2 2023 | $4,510,639 | -33.3% | 287,119 | -30.0% | 0.01% | -28.6% |
| Q1 2023 | $6,763,623 | +98.7% | 410,414 | +72.6% | 0.01% | +133.3% |
| Q1 2022 | $3,404,000 | +31.2% | 237,726 | +24.9% | 0.00% | +50.0% |
| Q4 2021 | $2,594,000 | +850.2% | 190,311 | +1168.7% | 0.00% | – |
| Q4 2020 | $273,000 | +1.9% | 15,000 | 0.0% | 0.00% | – |
| Q3 2020 | $268,000 | -0.4% | 15,000 | 0.0% | 0.00% | – |
| Q2 2020 | $269,000 | -91.1% | 15,000 | -92.5% | 0.00% | -100.0% |
| Q1 2020 | $3,037,000 | -80.5% | 200,080 | -74.7% | 0.01% | -72.2% |
| Q4 2019 | $15,608,000 | -59.8% | 791,110 | -64.9% | 0.02% | -61.7% |
| Q3 2019 | $38,812,000 | +50.5% | 2,256,527 | +54.9% | 0.05% | +42.4% |
| Q2 2019 | $25,781,000 | +121.8% | 1,456,560 | +155.3% | 0.03% | +120.0% |
| Q1 2019 | $11,621,000 | – | 570,477 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |